EGFR tyrosine kinase inhibitor
| EGFR tyrosine kinase inhibitor | |
|---|---|
| Term | EGFR tyrosine kinase inhibitor |
| Short definition | EGFR tyrosine kinase inhibitor (. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
EGFR tyrosine kinase inhibitor - (pronounced) (. . . TY-ruh-seen KY-nays in-HIH-bih-ter) A substance that blocks the activity of a protein called epidermal growth factor receptor (EGFR). . EGFR is found on the surface of some normal cells and is involved in cell growth. It can also be found in high levels on some types of cancer cells, causing those cells to grow and divide. Blocking EGFR can prevent cancer cells from growing. Some EGFR tyrosine kinase inhibitors are used to treat cancer. Also referred to as EGFR Inhibitor, Epidermal Growth Factor Receptor Inhibitor, and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
External links
- Medical encyclopedia article on EGFR tyrosine kinase inhibitor
- Wikipedia's article - EGFR tyrosine kinase inhibitor
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski